{"id":1556,"date":"2024-01-22T15:17:26","date_gmt":"2024-01-22T15:17:26","guid":{"rendered":"https:\/\/aaudz.com\/?page_id=1556"},"modified":"2024-01-22T15:21:30","modified_gmt":"2024-01-22T15:21:30","slug":"communication-presentes-18eme-congres-national-aau","status":"publish","type":"page","link":"https:\/\/aaudz.com\/index.php\/communication-presentes-18eme-congres-national-aau\/","title":{"rendered":"Communication pr\u00e9sentes 18eme congres national AAU"},"content":{"rendered":"

Communications pr\u00e9sent\u00e9es 2023<\/h1>\n

Jeudi 7 d\u00e9cembre 2023<\/h2>\n

Premi\u00e8re s\u00e9ance<\/h3>\n

Profil des patients et traitement du cancer de prostate au CHU Oran , \u00e9valuation sur 03 ans. T.E.H. taleb<\/a><\/p>\n

R\u00e9sultats fonctionnels de la PR \u00e0 propos d\u2019une s\u00e9rie de 70 malades A. Haddouche<\/a><\/p>\n

N\u00e9phrectomie partielle laparoscopique pour tumeurs r\u00e9nales, quel patch utiliser pour l\u2019h\u00e9mostase ? S. Rezkallah<\/a><\/p>\n

Epidemiological,clinical,histo-patlogical characteristics of renal cancer : about 268 cases. A. Ouldamar<\/a><\/p>\n

La surveillance active pour les petites masses r\u00e9nales : Pourquoi ? Pour qui ? et Comment ? Chelef Sidi Mohamed Amine<\/a><\/p>\n

Deuxi\u00e8me s\u00e9ance<\/h3>\n

Management des TVNIM \u00e0 haut risque dans le contexte Alg\u00e9rien en2023. C. Djeffal<\/a><\/p>\n

La dysfonction \u00e9rectile et l\u2019\u00e9v\u00e8nement cardio vasculaire en consultation de cardiologie : r\u00e9sultats pr\u00e9liminaires d\u2019une enqu\u00eate de pr\u00e9valence R. Boubaker<\/a><\/p>\n

Lorsque les tumeurs de vessie non infiltrant le muscle nous \u00e9chappent: Exp\u00e9rience du service de chirurgie urologique-transplantation – CHU Annaba M.l. Redjdal<\/a><\/p>\n

Highlights ESMO 2023: Cancers urolohiques. S. Za\u00efdi<\/a><\/p>\n

Cancer de la prostate oligo-m\u00e9tastatique. \u00ab Symposium Astra Zeneca \u00bb M. Benatta<\/a><\/p>\n

Troisi\u00e8me s\u00e9ance<\/h3>\n

S\u00e9ance vid\u00e9o<\/h3>\n

Communication vid\u00e9o: Trucs , Astuces et Rep\u00e8res anatomique dans les n\u00e9phrectomies coelioscopiques. k. Belkacemi<\/a><\/p>\n

Gestion endoscopique d\u2019un ph\u00e9ochromocytome v\u00e9sical M.L. REDJDAL<\/a><\/p>\n

 <\/p>\n

Vendredi 8 d\u00e9cembre 2023<\/h2>\n

Premi\u00e8re s\u00e9ance<\/h3>\n

Identifier les causes sp\u00e9cifiques de la perte d\u2019allogreffe r\u00e9nale : Une \u00e9tude bas\u00e9e sur la population H.E. Ouarhlent<\/a><\/p>\n

L\u2019int\u00e9r\u00eat du d\u00e9veloppement de la transplantation r\u00e9nale pr\u00e9emptive. H. Ouarhlent<\/a><\/p>\n

Adenomectomie coelioscopique robot. D. Zerizer<\/a><\/p>\n

Cancer du rein: Place de la Cryotherapie. R. Pramod<\/a><\/p>\n

Place de la radiologie interventionnelle dans le Traitement des m\u00e9tastases osseuses des tumeurs urotheliales. R.Pramod<\/a><\/p>\n

Surrenalectomie coelioscopique robot assist\u00e9e : Les limites de la voie coelioscopique. B. Benmohamed<\/a><\/p>\n

Biopsie prostatique trans-p\u00e9rin\u00e9ale : Indication, technique et complication. N. Deffar<\/a><\/p>\n

Deuxi\u00e8me s\u00e9ance<\/h3>\n

Table ronde: Cancer du rein localis\u00e9 \u00e0 haut risque Aspect diagnostique et th\u00e9rapeutique<\/a><\/p>\n

European School of Urology: A unique possibility for urological education. I. Ouzaid<\/a><\/p>\n

EAU Guidelines recommendations on prostate cancer A. Ingels<\/a><\/p>\n

Transperineal vs transrectal biopsy, end of the debate? I. Ouzaid<\/a><\/p>\n

Does PSMA change the role of surgery in prostate cancer? I. Ouzaid<\/a><\/p>\n

Multimodal treatment in oligo-metastatic disease I. Ouzaid<\/a><\/p>\n

Session AFU<\/h3>\n

Prostatectomie radicale : Trucs et Astuces. A.De la Taille<\/a><\/p>\n

Optimisation de l\u2019environnement op\u00e9ratoire en chirurgie canc\u00e9rologique urologique B. Malavaud<\/a><\/p>\n

Pr\u00e9vention m\u00e9dicale de la r\u00e9cidive lithiasique N. Abid<\/a><\/p>\n

Courbures cong\u00e9nitales de la verge A. Faix<\/a><\/p>\n

 <\/p>\n

Samedi 9 d\u00e9cembre 2023<\/h2>\n

Session SIU Lecture<\/h3>\n

\u00ab Improving outcomes of NIMBC \u00bb P. Coloby<\/a><\/p>\n

\u00ab How to treat BCG failure \u00bb P. Coloby<\/a><\/p>\n

Novel disposable Mini fURS T. Papatsoris<\/a><\/p>\n

Tips and tricks in PCNL T. Papatsoris<\/a><\/p>\n

Interactive case discussion P. Coloby<\/a><\/p>\n

Prise en charge de l\u2019\u00e9jaculation pr\u00e9coce. \u00ab Symposium Hikma \u00bb A. Faix<\/a><\/p>\n

\u00ab Symposium Hikma \u00bb Optimisation de la prise en charge des patients atteints de la cancer de la prostate \u00e0 haut risque I. Ouzaid<\/a><\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Communications pr\u00e9sent\u00e9es 2023 Jeudi 7 d\u00e9cembre 2023 Premi\u00e8re s\u00e9ance Profil […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"_eb_attr":"","footnotes":""},"class_list":["post-1556","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/aaudz.com\/index.php\/wp-json\/wp\/v2\/pages\/1556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aaudz.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aaudz.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aaudz.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aaudz.com\/index.php\/wp-json\/wp\/v2\/comments?post=1556"}],"version-history":[{"count":1,"href":"https:\/\/aaudz.com\/index.php\/wp-json\/wp\/v2\/pages\/1556\/revisions"}],"predecessor-version":[{"id":1594,"href":"https:\/\/aaudz.com\/index.php\/wp-json\/wp\/v2\/pages\/1556\/revisions\/1594"}],"wp:attachment":[{"href":"https:\/\/aaudz.com\/index.php\/wp-json\/wp\/v2\/media?parent=1556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}